Loading…
Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer
To analyse the prevalence of (pre) malignant lesions occurring in breast and adnexal tissue at prophylactic surgery in women at hereditary high risk of breast and/or ovarian cancers. Tissue was obtained from 85 women who underwent prophylactic bilateral salpingo‐oophorectomy (pBSO) and from 59 women...
Saved in:
Published in: | International journal of cancer 2006-09, Vol.119 (6), p.1412-1418 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4198-65062b00b0ccc6a6f8d964c540df82923dc4aea5539f67f2af6a128a7c419e5b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4198-65062b00b0ccc6a6f8d964c540df82923dc4aea5539f67f2af6a128a7c419e5b3 |
container_end_page | 1418 |
container_issue | 6 |
container_start_page | 1412 |
container_title | International journal of cancer |
container_volume | 119 |
creator | Hermsen, Brenda B.J. van Diest, Paul J. Berkhof, Johannes Menko, Fred H. Gille, Johan J.P. Piek, Jurgen M.J. Meijer, Sybren Winters, Henri A.H. Kenemans, Peter Mensdorff‐Pouilly, Silvia von Verheijen, René H.M. |
description | To analyse the prevalence of (pre) malignant lesions occurring in breast and adnexal tissue at prophylactic surgery in women at hereditary high risk of breast and/or ovarian cancers. Tissue was obtained from 85 women who underwent prophylactic bilateral salpingo‐oophorectomy (pBSO) and from 59 women who underwent prophylactic mastectomy (pM). Control tissue samples were obtained from women undergoing breast reduction surgery (N = 99) or adnexal surgery for benign reasons (N = 72). In women with a BRCA1/2 mutation, the prevalence of a (pre) malignant adnexal lesion was 50% (95% CI 26–74) if older than 40 years and 14% (95% CI 0–58) if younger. The prevalences of (pre) malignant breast lesions in women older than 40 years, with and without a BRCA1/2 mutation, were 0% (95% CI 0–16) and 47% (95% CI 21–73), respectively. No association was found between (pre) malignant lesions in breast and adnexal tissue occurring in 28 women who underwent surgery on both organs (R = 0.155, p = 0.432), but the prevalence of lesions was significantly higher in adnexal tissue than in the breast (p = 0.023). Compared to controls, women at hereditary high risk had a higher chance of (pre) malignant lesions in the breast and an even higher chance of such lesions in the adnexal tissue. There was no indication for concomitant presence of such lesions in both organs at the time of prophylactic surgery. The high frequency of (pre) malignant lesions in the adnexal tissue stresses further the importance of pBSO from the age of 40 onwards in women at hereditary high risk. © 2006 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/ijc.21988 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68762931</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17241190</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4198-65062b00b0ccc6a6f8d964c540df82923dc4aea5539f67f2af6a128a7c419e5b3</originalsourceid><addsrcrecordid>eNqFkUFv1DAQhS0EokvhwB9AvoDoIe3YSZzkiFYUilbiAudo4oy7Lk682Nmu-pP4lzi7kdoL4mTZ87335HmMvRVwKQDklb3Tl1I0df2MrQQ0VQZSlM_ZKs0gq0SuztirGO8AhCiheMnOhFKiFFCt2J-NP_BdoHt0NGri3vCP6XrBB3T2dsRx4o6i9WPkduTTlngXCOPEcez51t5un4oXwt9jeDgC1-ic31lM7_vuOD_4gUaOE99SoN5OM3m0CTb-mtOf2M8-s1ZjMg-v2QuDLtKb5TxnP68__1h_zTbfv9ysP20yXaQVZKoEJTuADrTWCpWp-0YVuiygN7VsZN7rAgnLMm-MqoxEo1DIGqtZTmWXn7MPJ99d8L_3FKd2sFGTcziS38dW1ZWSTS7-C4pKFkI0kMCLE6iDjzGQaXfBDunnrYB2LrBNBbbHAhP7bjHddwP1j-TSWALeLwBGjc6EtBwbH7kaZKUgT9zViTtYRw__Tmxvvq1P0X8B6jGzaw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17241190</pqid></control><display><type>article</type><title>Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Hermsen, Brenda B.J. ; van Diest, Paul J. ; Berkhof, Johannes ; Menko, Fred H. ; Gille, Johan J.P. ; Piek, Jurgen M.J. ; Meijer, Sybren ; Winters, Henri A.H. ; Kenemans, Peter ; Mensdorff‐Pouilly, Silvia von ; Verheijen, René H.M.</creator><creatorcontrib>Hermsen, Brenda B.J. ; van Diest, Paul J. ; Berkhof, Johannes ; Menko, Fred H. ; Gille, Johan J.P. ; Piek, Jurgen M.J. ; Meijer, Sybren ; Winters, Henri A.H. ; Kenemans, Peter ; Mensdorff‐Pouilly, Silvia von ; Verheijen, René H.M.</creatorcontrib><description>To analyse the prevalence of (pre) malignant lesions occurring in breast and adnexal tissue at prophylactic surgery in women at hereditary high risk of breast and/or ovarian cancers. Tissue was obtained from 85 women who underwent prophylactic bilateral salpingo‐oophorectomy (pBSO) and from 59 women who underwent prophylactic mastectomy (pM). Control tissue samples were obtained from women undergoing breast reduction surgery (N = 99) or adnexal surgery for benign reasons (N = 72). In women with a BRCA1/2 mutation, the prevalence of a (pre) malignant adnexal lesion was 50% (95% CI 26–74) if older than 40 years and 14% (95% CI 0–58) if younger. The prevalences of (pre) malignant breast lesions in women older than 40 years, with and without a BRCA1/2 mutation, were 0% (95% CI 0–16) and 47% (95% CI 21–73), respectively. No association was found between (pre) malignant lesions in breast and adnexal tissue occurring in 28 women who underwent surgery on both organs (R = 0.155, p = 0.432), but the prevalence of lesions was significantly higher in adnexal tissue than in the breast (p = 0.023). Compared to controls, women at hereditary high risk had a higher chance of (pre) malignant lesions in the breast and an even higher chance of such lesions in the adnexal tissue. There was no indication for concomitant presence of such lesions in both organs at the time of prophylactic surgery. The high frequency of (pre) malignant lesions in the adnexal tissue stresses further the importance of pBSO from the age of 40 onwards in women at hereditary high risk. © 2006 Wiley‐Liss, Inc.</description><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/ijc.21988</identifier><identifier>PMID: 16615107</identifier><identifier>CODEN: IJCNAW</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; Aged ; Biological and medical sciences ; BRCA1/2 ; breast ; Breast Neoplasms - genetics ; Breast Neoplasms - prevention & control ; Breast Neoplasms - surgery ; Fallopian Tube Neoplasms - genetics ; Fallopian Tube Neoplasms - prevention & control ; Fallopian Tube Neoplasms - surgery ; Female ; Female genital diseases ; Genes, BRCA1 ; Genes, BRCA2 ; Genetic Predisposition to Disease ; Gynecology. Andrology. Obstetrics ; Humans ; Mastectomy ; Medical sciences ; Middle Aged ; Ovarian Neoplasms - genetics ; Ovarian Neoplasms - prevention & control ; Ovarian Neoplasms - surgery ; Ovariectomy ; ovary ; premalignant lesions ; Prevalence ; Risk Factors ; Tumors</subject><ispartof>International journal of cancer, 2006-09, Vol.119 (6), p.1412-1418</ispartof><rights>Copyright © 2006 Wiley‐Liss, Inc.</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4198-65062b00b0ccc6a6f8d964c540df82923dc4aea5539f67f2af6a128a7c419e5b3</citedby><cites>FETCH-LOGICAL-c4198-65062b00b0ccc6a6f8d964c540df82923dc4aea5539f67f2af6a128a7c419e5b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18027603$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16615107$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hermsen, Brenda B.J.</creatorcontrib><creatorcontrib>van Diest, Paul J.</creatorcontrib><creatorcontrib>Berkhof, Johannes</creatorcontrib><creatorcontrib>Menko, Fred H.</creatorcontrib><creatorcontrib>Gille, Johan J.P.</creatorcontrib><creatorcontrib>Piek, Jurgen M.J.</creatorcontrib><creatorcontrib>Meijer, Sybren</creatorcontrib><creatorcontrib>Winters, Henri A.H.</creatorcontrib><creatorcontrib>Kenemans, Peter</creatorcontrib><creatorcontrib>Mensdorff‐Pouilly, Silvia von</creatorcontrib><creatorcontrib>Verheijen, René H.M.</creatorcontrib><title>Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>To analyse the prevalence of (pre) malignant lesions occurring in breast and adnexal tissue at prophylactic surgery in women at hereditary high risk of breast and/or ovarian cancers. Tissue was obtained from 85 women who underwent prophylactic bilateral salpingo‐oophorectomy (pBSO) and from 59 women who underwent prophylactic mastectomy (pM). Control tissue samples were obtained from women undergoing breast reduction surgery (N = 99) or adnexal surgery for benign reasons (N = 72). In women with a BRCA1/2 mutation, the prevalence of a (pre) malignant adnexal lesion was 50% (95% CI 26–74) if older than 40 years and 14% (95% CI 0–58) if younger. The prevalences of (pre) malignant breast lesions in women older than 40 years, with and without a BRCA1/2 mutation, were 0% (95% CI 0–16) and 47% (95% CI 21–73), respectively. No association was found between (pre) malignant lesions in breast and adnexal tissue occurring in 28 women who underwent surgery on both organs (R = 0.155, p = 0.432), but the prevalence of lesions was significantly higher in adnexal tissue than in the breast (p = 0.023). Compared to controls, women at hereditary high risk had a higher chance of (pre) malignant lesions in the breast and an even higher chance of such lesions in the adnexal tissue. There was no indication for concomitant presence of such lesions in both organs at the time of prophylactic surgery. The high frequency of (pre) malignant lesions in the adnexal tissue stresses further the importance of pBSO from the age of 40 onwards in women at hereditary high risk. © 2006 Wiley‐Liss, Inc.</description><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>BRCA1/2</subject><subject>breast</subject><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - prevention & control</subject><subject>Breast Neoplasms - surgery</subject><subject>Fallopian Tube Neoplasms - genetics</subject><subject>Fallopian Tube Neoplasms - prevention & control</subject><subject>Fallopian Tube Neoplasms - surgery</subject><subject>Female</subject><subject>Female genital diseases</subject><subject>Genes, BRCA1</subject><subject>Genes, BRCA2</subject><subject>Genetic Predisposition to Disease</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Mastectomy</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Ovarian Neoplasms - genetics</subject><subject>Ovarian Neoplasms - prevention & control</subject><subject>Ovarian Neoplasms - surgery</subject><subject>Ovariectomy</subject><subject>ovary</subject><subject>premalignant lesions</subject><subject>Prevalence</subject><subject>Risk Factors</subject><subject>Tumors</subject><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqFkUFv1DAQhS0EokvhwB9AvoDoIe3YSZzkiFYUilbiAudo4oy7Lk682Nmu-pP4lzi7kdoL4mTZ87335HmMvRVwKQDklb3Tl1I0df2MrQQ0VQZSlM_ZKs0gq0SuztirGO8AhCiheMnOhFKiFFCt2J-NP_BdoHt0NGri3vCP6XrBB3T2dsRx4o6i9WPkduTTlngXCOPEcez51t5un4oXwt9jeDgC1-ic31lM7_vuOD_4gUaOE99SoN5OM3m0CTb-mtOf2M8-s1ZjMg-v2QuDLtKb5TxnP68__1h_zTbfv9ysP20yXaQVZKoEJTuADrTWCpWp-0YVuiygN7VsZN7rAgnLMm-MqoxEo1DIGqtZTmWXn7MPJ99d8L_3FKd2sFGTcziS38dW1ZWSTS7-C4pKFkI0kMCLE6iDjzGQaXfBDunnrYB2LrBNBbbHAhP7bjHddwP1j-TSWALeLwBGjc6EtBwbH7kaZKUgT9zViTtYRw__Tmxvvq1P0X8B6jGzaw</recordid><startdate>20060915</startdate><enddate>20060915</enddate><creator>Hermsen, Brenda B.J.</creator><creator>van Diest, Paul J.</creator><creator>Berkhof, Johannes</creator><creator>Menko, Fred H.</creator><creator>Gille, Johan J.P.</creator><creator>Piek, Jurgen M.J.</creator><creator>Meijer, Sybren</creator><creator>Winters, Henri A.H.</creator><creator>Kenemans, Peter</creator><creator>Mensdorff‐Pouilly, Silvia von</creator><creator>Verheijen, René H.M.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U1</scope><scope>7U2</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>20060915</creationdate><title>Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer</title><author>Hermsen, Brenda B.J. ; van Diest, Paul J. ; Berkhof, Johannes ; Menko, Fred H. ; Gille, Johan J.P. ; Piek, Jurgen M.J. ; Meijer, Sybren ; Winters, Henri A.H. ; Kenemans, Peter ; Mensdorff‐Pouilly, Silvia von ; Verheijen, René H.M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4198-65062b00b0ccc6a6f8d964c540df82923dc4aea5539f67f2af6a128a7c419e5b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>BRCA1/2</topic><topic>breast</topic><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - prevention & control</topic><topic>Breast Neoplasms - surgery</topic><topic>Fallopian Tube Neoplasms - genetics</topic><topic>Fallopian Tube Neoplasms - prevention & control</topic><topic>Fallopian Tube Neoplasms - surgery</topic><topic>Female</topic><topic>Female genital diseases</topic><topic>Genes, BRCA1</topic><topic>Genes, BRCA2</topic><topic>Genetic Predisposition to Disease</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Mastectomy</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Ovarian Neoplasms - genetics</topic><topic>Ovarian Neoplasms - prevention & control</topic><topic>Ovarian Neoplasms - surgery</topic><topic>Ovariectomy</topic><topic>ovary</topic><topic>premalignant lesions</topic><topic>Prevalence</topic><topic>Risk Factors</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hermsen, Brenda B.J.</creatorcontrib><creatorcontrib>van Diest, Paul J.</creatorcontrib><creatorcontrib>Berkhof, Johannes</creatorcontrib><creatorcontrib>Menko, Fred H.</creatorcontrib><creatorcontrib>Gille, Johan J.P.</creatorcontrib><creatorcontrib>Piek, Jurgen M.J.</creatorcontrib><creatorcontrib>Meijer, Sybren</creatorcontrib><creatorcontrib>Winters, Henri A.H.</creatorcontrib><creatorcontrib>Kenemans, Peter</creatorcontrib><creatorcontrib>Mensdorff‐Pouilly, Silvia von</creatorcontrib><creatorcontrib>Verheijen, René H.M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hermsen, Brenda B.J.</au><au>van Diest, Paul J.</au><au>Berkhof, Johannes</au><au>Menko, Fred H.</au><au>Gille, Johan J.P.</au><au>Piek, Jurgen M.J.</au><au>Meijer, Sybren</au><au>Winters, Henri A.H.</au><au>Kenemans, Peter</au><au>Mensdorff‐Pouilly, Silvia von</au><au>Verheijen, René H.M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>2006-09-15</date><risdate>2006</risdate><volume>119</volume><issue>6</issue><spage>1412</spage><epage>1418</epage><pages>1412-1418</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><coden>IJCNAW</coden><abstract>To analyse the prevalence of (pre) malignant lesions occurring in breast and adnexal tissue at prophylactic surgery in women at hereditary high risk of breast and/or ovarian cancers. Tissue was obtained from 85 women who underwent prophylactic bilateral salpingo‐oophorectomy (pBSO) and from 59 women who underwent prophylactic mastectomy (pM). Control tissue samples were obtained from women undergoing breast reduction surgery (N = 99) or adnexal surgery for benign reasons (N = 72). In women with a BRCA1/2 mutation, the prevalence of a (pre) malignant adnexal lesion was 50% (95% CI 26–74) if older than 40 years and 14% (95% CI 0–58) if younger. The prevalences of (pre) malignant breast lesions in women older than 40 years, with and without a BRCA1/2 mutation, were 0% (95% CI 0–16) and 47% (95% CI 21–73), respectively. No association was found between (pre) malignant lesions in breast and adnexal tissue occurring in 28 women who underwent surgery on both organs (R = 0.155, p = 0.432), but the prevalence of lesions was significantly higher in adnexal tissue than in the breast (p = 0.023). Compared to controls, women at hereditary high risk had a higher chance of (pre) malignant lesions in the breast and an even higher chance of such lesions in the adnexal tissue. There was no indication for concomitant presence of such lesions in both organs at the time of prophylactic surgery. The high frequency of (pre) malignant lesions in the adnexal tissue stresses further the importance of pBSO from the age of 40 onwards in women at hereditary high risk. © 2006 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>16615107</pmid><doi>10.1002/ijc.21988</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0020-7136 |
ispartof | International journal of cancer, 2006-09, Vol.119 (6), p.1412-1418 |
issn | 0020-7136 1097-0215 |
language | eng |
recordid | cdi_proquest_miscellaneous_68762931 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Adult Aged Biological and medical sciences BRCA1/2 breast Breast Neoplasms - genetics Breast Neoplasms - prevention & control Breast Neoplasms - surgery Fallopian Tube Neoplasms - genetics Fallopian Tube Neoplasms - prevention & control Fallopian Tube Neoplasms - surgery Female Female genital diseases Genes, BRCA1 Genes, BRCA2 Genetic Predisposition to Disease Gynecology. Andrology. Obstetrics Humans Mastectomy Medical sciences Middle Aged Ovarian Neoplasms - genetics Ovarian Neoplasms - prevention & control Ovarian Neoplasms - surgery Ovariectomy ovary premalignant lesions Prevalence Risk Factors Tumors |
title | Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T05%3A57%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low%20prevalence%20of%20(pre)%20malignant%20lesions%20in%20the%20breast%20and%20high%20prevalence%20in%20the%20ovary%20and%20Fallopian%20tube%20in%20women%20at%20hereditary%20high%20risk%20of%20breast%20and%20ovarian%20cancer&rft.jtitle=International%20journal%20of%20cancer&rft.au=Hermsen,%20Brenda%20B.J.&rft.date=2006-09-15&rft.volume=119&rft.issue=6&rft.spage=1412&rft.epage=1418&rft.pages=1412-1418&rft.issn=0020-7136&rft.eissn=1097-0215&rft.coden=IJCNAW&rft_id=info:doi/10.1002/ijc.21988&rft_dat=%3Cproquest_cross%3E17241190%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4198-65062b00b0ccc6a6f8d964c540df82923dc4aea5539f67f2af6a128a7c419e5b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17241190&rft_id=info:pmid/16615107&rfr_iscdi=true |